Epidemiological method

Last updated

The science of epidemiology has matured significantly from the times of Hippocrates, Semmelweis and John Snow. The techniques for gathering and analyzing epidemiological data vary depending on the type of disease being monitored but each study will have overarching similarities. [1]

Contents

Outline of the process of an epidemiological study

  1. Establish that a problem exists
    • Full epidemiological studies are expensive and laborious undertakings. Before any study is started, a case must be made for the importance of the research.
  2. Confirm the homogeneity of the events
    • Any conclusions drawn from inhomogeneous cases will be suspicious. All events or occurrences of the disease must be true cases of the disease.
  3. Collect all the events
    • It is important to collect as much information as possible about each event in order to inspect a large number of possible risk factors. The events may be collected from varied methods of epidemiological study or from censuses or hospital records.
    • The events can be characterized by Incidence rates and prevalence rates.
    • Often, occurrence of a single disease entity is set as an event.
    • Given inherent heterogeneous nature of any given disease (i.e., the unique disease principle [2] ), a single disease entity may be treated as disease subtypes. [3] This framework is well conceptualized in the interdisciplinary field of molecular pathological epidemiology (MPE). [4] [5]
  4. Characterize the events as to epidemiological factors
    1. Predisposing factors
      • Non-environmental factors that increase the likelihood of getting a disease. Genetic history, age, and gender are examples.
    2. Enabling/disabling factors
      • Factors relating to the environment that either increase or decrease the likelihood of disease. Exercise and good diet are examples of disabling factors. A weakened immune system and poor nutrition are examples of enabling factors.
    3. Precipitation factors
      • This factor is the most important in that it identifies the source of exposure. It may be a germ, toxin or gene.
    4. Reinforcing factors
      • These are factors that compound the likelihood of getting a disease. They may include repeated exposure or excessive environmental stresses.
  5. Look for patterns and trends
    • Here one looks for similarities in the cases which may identify major risk factors for contracting the disease. Epidemic curves may be used to identify such risk factors.
  6. Formulate a hypothesis
    • If a trend has been observed in the cases, the researcher may postulate as to the nature of the relationship between the potential disease-causing agent and the disease.
  7. Test the hypothesis
    • Because epidemiological studies can rarely be conducted in a laboratory the results are often polluted by uncontrollable variations in the cases. This often makes the results difficult to interpret. Two methods have evolved to assess the strength of the relationship between the disease causing agent and the disease.
    • Koch's postulates were the first criteria developed for epidemiological relationships. Because they only work well for highly contagious bacteria and toxins, this method is largely out of favor.
    • Bradford-Hill Criteria are the current standards for epidemiological relationships. A relationship may fill all, some, or none of the criteria and still be true.
  8. Publish the results. [6]

Measures

Epidemiologists are famous for their use of rates. Each measure serves to characterize the disease giving valuable information about contagiousness, incubation period, duration, and mortality of the disease.[ citation needed ]

Measures of occurrence

  1. Incidence measures
    1. Incidence rate, where cases included are defined using a case definition
    2. Hazard rate
    3. Cumulative incidence
  2. Prevalence measures
    1. Point prevalence
    2. Period prevalence

Measures of association

  1. Relative measures
    1. Risk ratio
    2. Rate ratio
    3. Odds ratio
    4. Hazard ratio
  2. Absolute measures
    1. Absolute risk reduction
    2. Attributable risk
      1. Attributable risk in exposed
      2. Percent attributable risk
      3. Levin's attributable risk

Other measures

  1. Virulence and Infectivity
  2. Mortality rate and Morbidity rate
  3. Case fatality
  4. Sensitivity (tests) and Specificity (tests)

Limitations

Epidemiological (and other observational) studies typically highlight associations between exposures and outcomes, rather than causation. While some consider this a limitation of observational research, epidemiological models of causation (e.g. Bradford Hill criteria) [7] contend that an entire body of evidence is needed before determining if an association is truly causal. [8] Moreover, many research questions are impossible to study in experimental settings, due to concerns around ethics and study validity. For example, the link between cigarette smoke and lung cancer was uncovered largely through observational research; however research ethics would certainly prohibit conducting a randomized trial of cigarette smoking once it had already been identified as a potential health threat.[ citation needed ]

See also

Related Research Articles

<span class="mw-page-title-main">Epidemiology</span> Study of health and disease within a population

Epidemiology is the study and analysis of the distribution, patterns and determinants of health and disease conditions in a defined population.

In epidemiology, prevalence is the proportion of a particular population found to be affected by a medical condition at a specific time. It is derived by comparing the number of people found to have the condition with the total number of people studied and is usually expressed as a fraction, a percentage, or the number of cases per 10,000 or 100,000 people. Prevalence is most often used in questionnaire studies.

<span class="mw-page-title-main">Incidence (epidemiology)</span> Chance over time of a medical condition

In epidemiology, incidence is a measure of the probability of occurrence of a given medical condition in a population within a specified period of time. Although sometimes loosely expressed simply as the number of new cases during some time period, it is better expressed as a proportion or a rate with a denominator.

Pathogenesis is the process by which a disease or disorder develops. It can include factors which contribute not only to the onset of the disease or disorder, but also to its progression and maintenance. The word comes from Greek πάθος pathos 'suffering, disease' and γένεσις genesis 'creation'.

<span class="mw-page-title-main">Case–control study</span> Type of observational study comparing two existing groups differing in outcome

A case–control study is a type of observational study in which two existing groups differing in outcome are identified and compared on the basis of some supposed causal attribute. Case–control studies are often used to identify factors that may contribute to a medical condition by comparing subjects who have that condition/disease with patients who do not have the condition/disease but are otherwise similar. They require fewer resources but provide less evidence for causal inference than a randomized controlled trial. A case–control study is often used to produce an odds ratio, which is an inferior measure of strength of association compared to relative risk, but new statistical methods make it possible to use a case-control study to estimate relative risk, risk differences, and other quantities.

In epidemiology, a risk factor or determinant is a variable associated with an increased risk of disease or infection.

An environmental factor, ecological factor or eco factor is any factor, abiotic or biotic, that influences living organisms. Abiotic factors include ambient temperature, amount of sunlight, and pH of the water soil in which an organism lives. Biotic factors would include the availability of food organisms and the presence of biological specificity, competitors, predators, and parasites.

<span class="mw-page-title-main">Relative risk</span> Measure of association used in epidemiology

The relative risk (RR) or risk ratio is the ratio of the probability of an outcome in an exposed group to the probability of an outcome in an unexposed group. Together with risk difference and odds ratio, relative risk measures the association between the exposure and the outcome.

The epidemiology of autism is the study of the incidence and distribution of autism spectrum disorders (ASD). A 2022 systematic review of global prevalence of autism spectrum disorders found a median prevalence of 1% in children in studies published from 2012 to 2021, with a trend of increasing prevalence over time. However, the study's 1% figure may reflect an underestimate of prevalence in low- and middle-income countries.

Molecular pathology is an emerging discipline within pathology which is focused in the study and diagnosis of disease through the examination of molecules within organs, tissues or bodily fluids. Molecular pathology shares some aspects of practice with both anatomic pathology and clinical pathology, molecular biology, biochemistry, proteomics and genetics, and is sometimes considered a "crossover" discipline. It is multi-disciplinary in nature and focuses mainly on the sub-microscopic aspects of disease. A key consideration is that more accurate diagnosis is possible when the diagnosis is based on both the morphologic changes in tissues and on molecular testing.

<span class="mw-page-title-main">Environmental epidemiology</span>

Environmental epidemiology is a branch of epidemiology concerned with determining how environmental exposures impact human health. This field seeks to understand how various external risk factors may predispose to or protect against disease, illness, injury, developmental abnormalities, or death. These factors may be naturally occurring or may be introduced into environments where people live, work, and play.

Molecular epidemiology is a branch of epidemiology and medical science that focuses on the contribution of potential genetic and environmental risk factors, identified at the molecular level, to the etiology, distribution and prevention of disease within families and across populations. This field has emerged from the integration of molecular biology into traditional epidemiological research. Molecular epidemiology improves our understanding of the pathogenesis of disease by identifying specific pathways, molecules and genes that influence the risk of developing disease. More broadly, it seeks to establish understanding of how the interactions between genetic traits and environmental exposures result in disease.

In epidemiology, ecological studies are used to understand the relationship between outcome and exposure at a population level, where 'population' represents a group of individuals with a shared characteristic such as geography, ethnicity, socio-economic status of employment. What differentiates ecological studies from other studies is that the unit analysis being studied is the group, therefore inferences cannot be made about individual study participants. On the other hand, details of outcome and exposure can be generalized to the population being studied. Examples of such studies include investigating associations between units of grouped data, such as electoral wards, regions, or even whole countries.

<span class="mw-page-title-main">Epidemiology of cancer</span> The study of factors in cancer causes and treatments

The epidemiology of cancer is the study of the factors affecting cancer, as a way to infer possible trends and causes. The study of cancer epidemiology uses epidemiological methods to find the cause of cancer and to identify and develop improved treatments.

The Bradford Hill criteria, otherwise known as Hill's criteria for causation, are a group of nine principles that can be useful in establishing epidemiologic evidence of a causal relationship between a presumed cause and an observed effect and have been widely used in public health research. They were established in 1965 by the English epidemiologist Sir Austin Bradford Hill.

Population impact measures (PIMs) are biostatistical measures of risk and benefit used in epidemiological and public health research. They are used to describe the impact of health risks and benefits in a population, to inform health policy.

<span class="mw-page-title-main">Nutritional epidemiology</span> Field of medical research on disease and diet

Nutritional epidemiology examines dietary and nutritional factors in relation to disease occurrence at a population level. Nutritional epidemiology is a relatively new field of medical research that studies the relationship between nutrition and health. It is a young discipline in epidemiology that is continuing to grow in relevance to present-day health concerns. Diet and physical activity are difficult to measure accurately, which may partly explain why nutrition has received less attention than other risk factors for disease in epidemiology. Nutritional epidemiology uses knowledge from nutritional science to aid in the understanding of human nutrition and the explanation of basic underlying mechanisms. Nutritional science information is also used in the development of nutritional epidemiological studies and interventions including clinical, case-control and cohort studies. Nutritional epidemiological methods have been developed to study the relationship between diet and disease. Findings from these studies impact public health as they guide the development of dietary recommendations including those tailored specifically for the prevention of certain diseases, conditions and cancers. It is argued by western researchers that nutritional epidemiology should be a core component in the training of all health and social service professions because of its increasing relevance and past successes in improving the health of the public worldwide. However, it is also argued that nutritional epidemiological studies yield unreliable findings as they rely on the role of diet in health and disease, which is known as an exposure that is susceptible to considerable measurement error.

Molecular pathological epidemiology is a discipline combining epidemiology and pathology. It is defined as "epidemiology of molecular pathology and heterogeneity of disease". Pathology and epidemiology share the same goal of elucidating etiology of disease, and MPE aims to achieve this goal at molecular, individual and population levels. Typically, MPE utilizes tissue pathology resources and data within existing epidemiology studies. Molecular epidemiology broadly encompasses MPE and conventional-type molecular epidemiology with the use of traditional disease designation systems.

Shuji Ogino is a molecular pathological epidemiologist, pathologist, and epidemiologist. He is currently Professor of Pathology at Harvard Medical School and Brigham and Women's Hospital, and Professor in the Department of Epidemiology at Harvard T.H. Chan School of Public Health. He is also Chief of Program in MPE Molecular Pathological Epidemiology at Brigham and Women's Hospital, and an associate member of Broad Institute of MIT and Harvard. He has been known for his work on establishing a new discipline, molecular pathological epidemiology, which represents an interdisciplinary science of molecular pathology and epidemiology.

<span class="mw-page-title-main">Forensic epidemiology</span>

The discipline of forensic epidemiology (FE) is a hybrid of principles and practices common to both forensic medicine and epidemiology. FE is directed at filling the gap between clinical judgment and epidemiologic data for determinations of causality in civil lawsuits and criminal prosecution and defense.

References

  1. ↑ Miquel Porta (2014) A dictionary of epidemiology , 6th edn, New York: Oxford University Press. ISBN   9780199976737.
  2. ↑ Ogino S, Lochhead P, Chan AT, Nishihara R, Cho E, Wolpin BM, Meyerhardt JA, Meissner A, Schernhammer ES, Fuchs CS, Giovannucci E (April 2013). "Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease". Modern Pathology. 26 (4): 465–84. doi:10.1038/modpathol.2012.214. PMC   3637979 . PMID   23307060.
  3. ↑ Begg CB (August 2011). "A strategy for distinguishing optimal cancer subtypes". International Journal of Cancer. 129 (4): 931–7. doi:10.1002/ijc.25714. PMC   3043163 . PMID   20949563.
  4. ↑ Ogino S, Stampfer M (March 2010). "Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology". Journal of the National Cancer Institute. 102 (6): 365–7. doi:10.1093/jnci/djq031. PMC   2841039 . PMID   20208016.
  5. ↑ Ogino S, Chan AT, Fuchs CS, Giovannucci E (March 2011). "Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field". Gut. 60 (3): 397–411. doi:10.1136/gut.2010.217182. PMC   3040598 . PMID   21036793.
  6. ↑ Austin DF, Werner SB (1982). Epidemiology for the health sciences: a primer on epidemiologic concepts and their uses (7th ed.). Springfield, Ill.: Charles C. Thomas. ISBN   978-0-398-02949-4.
  7. ↑ Fedak KM, Bernal A, Capshaw ZA, Gross S (2015-09-30). "Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology". Emerging Themes in Epidemiology. 12: 14. doi: 10.1186/s12982-015-0037-4 . PMC   4589117 . PMID   26425136.
  8. ↑ "Causal Inference". Boston University School of Public Health. Retrieved 2018-04-01.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.